Concepedia

Kevin J. Scanlon

KJ

Statistics

Publications

58

Citations

2.9K

H-Index

33

Active since

1979

Affiliations

City Of Hope National Medical Center(Current)

Tokai University

Yale University

University of California, San Francisco

Keck Graduate Institute

Kevin J. Scanlon is an author at City Of Hope National Medical Center specializing in medicine, oncology, and molecular oncology.

Publications per year

1979–2017

58

Publications

58

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.

Kevin J. Scanlon, Edward M. Newman, Yuzhi Lu et al. · Proceedings of the National Academy of Sciences · 1986 · 369 citations

, , +16

Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein.

Kevin J. Scanlon, Lu Jiao, Tadao Funato et al. · Proceedings of the National Academy of Sciences · 1991 · 210 citations

, , +15

Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme.

Mohammed Kashani–Sabet, Tadao Funato, Kevin J. Scanlon · PubMed · 1994 · 118 citations

, , +17

Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells.

Kevin J. Scanlon, Robert Safirstein, H. Thies et al. · PubMed · 1983 · 111 citations

, , +13

Molecular basis of cisplatin resistance in human carcinomas: model systems and patients.

Kevin J. Scanlon, Mohammed Kashani–Sabet, Hayato Miyachi et al. · PubMed · 1990 · 105 citations

, , +17

1–5 of 58